Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Nanomedicine ; 21: 102060, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31336175

RESUMO

G-rich oligonucleotide, AS1411, has been shown to interact with nucleolin and to inhibit cancer cell proliferation and tumor growth. This antiproliferative action is increased when AS1411 is conjugated to different types of nanoparticles. However, the molecular mechanisms are not known. In this work, we show in several cell lines that optimized AS1411-conjugated gold nanoparticles (GNS-AS1411) inhibit nucleolin expression at the RNA and protein levels. We observed an alteration of the nucleolar structure with a decrease of ribosomal RNA accumulation comparable to what is observed upon nucleolin knock down. However, the expression of genes involved in cell cycle and the cell cycle blockage by GNS-AS1411 are not regulated in the same way as that in cells where nucleolin has been knocked down. These data suggest that the anti-proliferative activity of GNS-AS1411 is not the only consequence of nucleolin targeting and down-regulation.


Assuntos
Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Regulação para Baixo/efeitos dos fármacos , Ouro , Nanopartículas Metálicas/química , Oligodesoxirribonucleotídeos , Fosfoproteínas/biossíntese , RNA Ribossômico/biossíntese , Proteínas de Ligação a RNA/biossíntese , Aptâmeros de Nucleotídeos , Linhagem Celular Tumoral , Ouro/química , Ouro/farmacologia , Humanos , Oligodesoxirribonucleotídeos/química , Oligodesoxirribonucleotídeos/farmacologia , Nucleolina
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa